Neurodevelopment Outcomes Following Severe Hand Foot and Mouth Disease in Vietnam

计划入组 243 人 · 首次发布于 2014 年 2 月 19 日

Propolis as a Treatment Option for Hand Foot and Mouth Disease

计划入组 200 人 · 首次发布于 2024 年 6 月 12 日

Hand, Foot, and Mouth Disease: Could EPs®7630 be a Treatment Option

计划入组 240 人 · 首次发布于 2024 年 4 月 9 日

Recombinant tetravalent Hand, foot and mouth disease vaccine (Reco-bio)

inactivated tetravalent vaccine (EV71/ CA10/ CA16 /CA6, hand foot and mouth disease)

Hand, foot and mouth vaccine (Emergex)

American College Of Foot And Ankle Surgeons

United States

HAND, WANDA

United States

The Trustee for Sydney Orthopaedic Foot and Ankle Research Institute

Australia

Vietnam Approves First Enterovirus A71 Vaccine as MVC and Substipharm Target Southeast Asian Expansion

Sinovac Launches Phase III Trial of Bivalent HFMD Vaccine

SINOVAC Posts 12.9% Revenue Growth on Overseas Expansion, Advances Late-Stage Vaccine Pipeline